Brooks Hill Partners

Check out our recent Industry Report on Clinical Decision Support Systems (CDSS). We explore how clinical decision support systems (CDSS) have advanced in recent years, now garnering significant adoption and market investment. #clinicaldecisionsupport #industryreport

In a phenomenon termed "metabolic reprogramming," cancer cells hijack normal metabolic processes to facilitate their own proliferation. As the complexity of metabolic dysregulation continues to be elucidated, scientists are looking for therapeutic avenues. #cancer #metabolism #drugdiscovery

The opioid crisis in the US continues to grow, taking the lives of thousands of people annually. Vaccines have emerged as a promising mechanism to prevent opioid overdose, with a fentanyl vaccine expected to enter clinical trials in 2024. Click the link to learn more. #opioidcrisis #fentanyl #vaccines

Our post-pandemic world has witnessed an acceleration in the adoption of decentralized clinical trials (DCTs). By harnessing telemedicine, wearable devices, and remote patient monitoring, DCTs mitigate many of the accessibility issues hindering patient recruitment. Click the link to learn more. #decentralizedclinicaltrials #clinicaltrials #drugdevelopment

Drugmakers have been increasingly turning to digital twin technology to plan, track, review, and improve their manufacturing processes. Amidst continued drug shortages, digitally simulating potential scenarios could provide the key to building supply chain resiliency moving forward. Click the link to learn more. #pharmasupplychain #digitaltwins #drugshortages

Faced with challenging patient recruitment processes and staggeringly low clinical trial success rates, biopharma companies have been increasingly turning to real-world evidence (RWE) to improve the planning and design of their clinical trials. Click the link to learn more. #biopharma #clinicaltrials #realworldevidence

Interleukins, a group of signaling molecules in the immune system, have gained traction in recent years for their potential in cancer therapy. By modulating the immune system, interleukins can super-power other immunotherapies. Clink the link to learn more. #cancer #treatment #interleukins

The digitization of healthcare is long overdue, with a central hurdle being the sensitivity and privacy of patient data. With the AI revolution already underway, will synthetic data come to the rescue for the healthcare industry? Click the link to learn more. #syntheticdata #ai #healthcare

The US has been grappling with a dire drug shortage crisis, with the number of drugs in short supply reaching a peak since 2014 at the beginning of this year. Yet, effectively responding to the crisis has proved as complicated as the pharmaceutical supply chain itself. Click the link to learn more. #drugshortages #supplychain #pharma